THYROCARE Share Price Target 2040

CAGR-based price projection for Thyrocare Technologies Limited (THYROCARE) targeting 2040, derived from official NSE exchange closing prices.

Bear Case (13.5% CAGR)
Rs 3,139
2040 Target
Base Case (33.7% CAGR)
Rs 31,233
2040 Target
Bull Case (102.5% CAGR)
Rs 10,405,587
2040 Target

Current Market Snapshot

CMP: Rs 533.60
52W High: Rs 649.35
52W Low: Rs 387.50
1Y CAGR: 78.8%
3Y CAGR: 33.7%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 606 Rs 714 Rs 1,081
2028 Rs 687 Rs 954 Rs 2,188
2029 Rs 780 Rs 1,276 Rs 4,431
2030 Rs 885 Rs 1,707 Rs 8,973
2031 Rs 1,005 Rs 2,283 Rs 18,171
2032 Rs 1,140 Rs 3,053 Rs 36,797
2033 Rs 1,294 Rs 4,082 Rs 74,515
2034 Rs 1,469 Rs 5,460 Rs 150,894
2035 Rs 1,667 Rs 7,301 Rs 305,566
2036 Rs 1,892 Rs 9,764 Rs 618,782
2037 Rs 2,147 Rs 13,058 Rs 1,253,055
2038 Rs 2,437 Rs 17,463 Rs 2,537,478
2039 Rs 2,766 Rs 23,355 Rs 5,138,477
2040 Rs 3,139 Rs 31,233 Rs 10,405,587

Other THYROCARE Price Targets

2025 2026 2027 2028 2030 2035 2050

Frequently Asked Questions

What is the THYROCARE share price target for 2040?

Based on historical growth analysis, the THYROCARE share price target for 2040 ranges from Rs 3,139 (conservative) to Rs 31,233 (base case) to Rs 10,405,587 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of THYROCARE?

The current market price of THYROCARE (Thyrocare Technologies Limited) is Rs 533.60. The 52-week high is Rs 649.35 and 52-week low is Rs 387.50.

Is THYROCARE a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for THYROCARE price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 13.5% CAGR), Base (33.7% CAGR), and Bull (optimistic at 102.5% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.